Related Experiment Video
Updated: Nov 29, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
miR-106a-5p Functions as a Tumor Suppressor by Targeting VEGFA in Renal Cell Carcinoma
Jun Ma1, Wenguang Wang1, Baihetiya Azhati1
1Department of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China.
Abstract:
MicroRNAs (miRNAs) regulate progression of different cancers. Nevertheless, there is limited information regarding the role of miR-106a-5p in renal cell carcinoma (RCC). Herein, we demonstrate that miR-106a-5p levels are drastically decreased in clear cell RCC (ccRCC) tissues and cell lines, which subsequently contribute to a poor patient overall survival and a high tumor stage. By screening and analyzing, we found that miR-106a-5p directly targets the 3'-UTR of the VEGFA mRNA and led to a decrease in VEGFA. This process is important for tumor cells' growth and colony formation, and overexpression of miR-106a-5p can especially kill kidney tumor cells. Therefore, our data reveal that miR-106a-5p functions as a tumor suppressor by regulating VEGFA and ccRCC may be susceptible to miR-106a-5p therapy.
Insights
MicroRNA-106a-5p (miR-106a-5p) is significantly reduced in kidney cancer, impacting survival. Restoring miR-106a-5p levels may offer a new therapeutic strategy for clear cell renal cell carcinoma (ccRCC).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression implicated in various cancers.
- The specific role of microRNA-106a-5p (miR-106a-5p) in renal cell carcinoma (RCC) remains largely unexplored.
- Understanding miRNA roles is vital for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the expression and function of miR-106a-5p in clear cell renal cell carcinoma (ccRCC).
- To identify the molecular targets of miR-106a-5p within ccRCC.
- To evaluate the therapeutic potential of miR-106a-5p in ccRCC.
Main Methods:
- Quantitative real-time PCR to measure miR-106a-5p expression in ccRCC tissues and cell lines.
- Bioinformatic analysis and luciferase reporter assays to identify and validate miR-106a-5p targets.
- In vitro assays to assess the impact of miR-106a-5p on ccRCC cell proliferation, colony formation, and viability.
Main Results:
- miR-106a-5p expression was significantly downregulated in ccRCC tissues and cell lines compared to normal controls.
- Lower miR-106a-5p levels correlated with advanced tumor stage and poorer patient survival.
- VEGFA was identified as a direct target of miR-106a-5p, with its expression reduced upon miR-106a-5p upregulation.
- Overexpression of miR-106a-5p inhibited ccRCC cell growth, colony formation, and induced cell death.
Conclusions:
- miR-106a-5p acts as a tumor suppressor in ccRCC by directly targeting VEGFA.
- Reduced miR-106a-5p expression is a potential biomarker for poor prognosis in ccRCC.
- miR-106a-5p represents a promising candidate for novel therapeutic strategies against ccRCC.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

